DIABETIC NEPHROPATHY
ACUTE COMPLICATIONS OF
             DIABETES MILLETUS
• DIABETIC KETO-ACIDOSIS (DKA)

• INSULIN SHOCK

• HYPERGLYCEMIC, HYPEROSMOLAR,
  NONKETOTIC (HHONK) COMA

• SOMOGYI EFFECT
D.K.A.
              PATHOPHYSIOLOGY
                         NO INSULIN


  OSMOTIC
DEHYDRATION         MARKED HYPERGLYCEMIA




   GLUCOSURIA             LIPOLYSIS
                                            CELLULAR
                                             HUNGER
  OSMOTIC
  DIURESIS      WEIGHT
                 LOSS        KETOACIDOSIS
                                            POLYPHAGIA
  POLYURIA
                POLYDIPSIA
D.K.A.
S/SX:
•   S/SX OF DM +
•   KETONURIA
•   METABOLIC ACIDOSIS
•   KUSSMAUL’S RESPIRATION
•   ACETONE BREATH
•   DHN
•   FLUSHED FACE
•   TACHYCARDIA
•   CIRCULATORY COLLAPSE COMA   DEATH
COMPLICATIONS OF DIABETES

• Acute:
  DKA
  Hypoglycemia
• Late-onset:
  Retinopathy
  Neuropathy
  Nephropathy
  Ischemic heart disease & stroke
Treatment of Diabetic Nephropathy

• End stage renal disease is a major cause of death and
  disability among diabetics
• Blood pressure reduction is an important initial step
  in slowing the progression of diabetic nephropathy
• Randomized, blinded outcomes trials that
  demonstrate a clear renoprotective benefit of ACE
  inhibitors in diabetes have been conducted only in
  type 1 diabetics
• Three recently completed randomized blinded trials
  address the previously unanswered questions of
  whether ARBs delay the progression of diabetic
  nephropathy (RENAAL, IDNT) or reduce proteinuria
  (IRMA II) in patients with type 2 diabetes
                                         www.hypertensiononline.org
Diabetic nephropathy

Diabetic nephropathy

  • 1.
  • 2.
    ACUTE COMPLICATIONS OF DIABETES MILLETUS • DIABETIC KETO-ACIDOSIS (DKA) • INSULIN SHOCK • HYPERGLYCEMIC, HYPEROSMOLAR, NONKETOTIC (HHONK) COMA • SOMOGYI EFFECT
  • 3.
    D.K.A. PATHOPHYSIOLOGY NO INSULIN OSMOTIC DEHYDRATION MARKED HYPERGLYCEMIA GLUCOSURIA LIPOLYSIS CELLULAR HUNGER OSMOTIC DIURESIS WEIGHT LOSS KETOACIDOSIS POLYPHAGIA POLYURIA POLYDIPSIA
  • 4.
    D.K.A. S/SX: • S/SX OF DM + • KETONURIA • METABOLIC ACIDOSIS • KUSSMAUL’S RESPIRATION • ACETONE BREATH • DHN • FLUSHED FACE • TACHYCARDIA • CIRCULATORY COLLAPSE COMA DEATH
  • 5.
    COMPLICATIONS OF DIABETES •Acute: DKA Hypoglycemia • Late-onset: Retinopathy Neuropathy Nephropathy Ischemic heart disease & stroke
  • 6.
    Treatment of DiabeticNephropathy • End stage renal disease is a major cause of death and disability among diabetics • Blood pressure reduction is an important initial step in slowing the progression of diabetic nephropathy • Randomized, blinded outcomes trials that demonstrate a clear renoprotective benefit of ACE inhibitors in diabetes have been conducted only in type 1 diabetics • Three recently completed randomized blinded trials address the previously unanswered questions of whether ARBs delay the progression of diabetic nephropathy (RENAAL, IDNT) or reduce proteinuria (IRMA II) in patients with type 2 diabetes www.hypertensiononline.org